Pediatric-onset MS, MOGAD and other neuroinflammatory disorders of childhood are believed to represent the earliest manifestations of analogous pathophysiological processes underlying adult-onset forms of these same diseases. Due to the increase in comorbidities and environmental exposures that come with aging, focusing on novel disease-related targets in children can shed light on mechanisms driving the development, evolution, and persistence of neuroinflammation in humans across the lifespan. This webinar will focus on the latest research updates from the US Network of Pediatric MS Centers.
Aaron Abrams, MD
Dr. Aaron Abrams is Co-Director of the Pediatric MS and Neuroimmunology Program at Cleveland Clinic and serves on the Steering Committee of the US Network of Pediatric MS Centers. His research focuses on improving transitions from pediatric- to adult-focused care, as well as other aspects of the management and treatment of neuroinflammatory disorders in childhood.
Organizer: CNS Scientific Research Committee